Table 4. The lifetime attributable risk (LAR) of secondary malignancy in the organs at exposure summed to 100 years (mean ± standard deviation).
| Site | Lifetime attributable risk (among 100,000 population) | ||||
|---|---|---|---|---|---|
| 3D-CRT | FinF | IMRT | VMAT | TOMO | |
| Ipsilateral lung | 1474 ± 270 | 1511 ± 263 | 1408 ± 390 | 2851 ± 532 | 1374 ± 244 |
| Contralateral lung | 129 ± 73 | 120 ± 61 | 134 ± 53 | 746 ± 639 | 154 ± 40 |
| Contralateral breast | 95 ± 34 | 104 ± 38 | 83 ± 46 | 355 ± 148 | 83 ± 19 |
| Thyroid | 506 ± 176 | 496 ± 192 | 868 ± 280 | 1013 ± 573 | 255 ± 55 |
| Liver | 42 ± 16 | 44 ± 15 | 60 ± 12 | 79 ± 36 | 33 ± 10 |
| Stomach | 100 ± 47 | 107 ± 45 | 146 ± 29 | 162 ± 40 | 55 ± 15 |
| Colon | 85 ± 51 | 94 ± 55 | 237 ± 80 | 181 ± 60 | 87 ± 12 |
| Gonad | 6 ± 3 | 7 ± 3 | 29 ± 10 | 19 ± 4 | 12 ± 1 |
| Rectum | 11 ± 4 | 14 ± 4 | 62 ± 21 | 36 ± 5 | 30 ± 5 |
| Total | 2448 ± 340 | 2497 ± 341 | 2965 ± 493 | 5442 ± 1024 | 2083 ± 255 |